News

ISOQOL Annual Conference 2022 – attend our workshop

ISOQOL Annual Conference 2022 – attend our workshop

The 29th annual ISOQOL conference is taking place in Prague, October 19–22. This year, the theme will be “Redefining boundaries – breaking new ground in patient-centered outcomes research”. We’ll be there, will you?
We will be hosting a workshop on “Balancing measurement science with user experience practices in eCOA migration” on the first day of the conference at 9am local time.

read more
MyRealWorld™ MG: Study launch in Denmark

MyRealWorld™ MG: Study launch in Denmark

The MyRealWorld™ MG (MRW MG) study about the impact of myasthenia gravis on patients’ lives has added Denmark to its list of study countries. This means that the digital real-world evidence study, which has been ongoing since December 2019, now operates across nine countries: the US, Canada, Japan, Germany, the UK, France, Italy, Spain, and most recently, Denmark.

read more
Vitaccess receives ISO 9001 and ISO 27001 certifications

Vitaccess receives ISO 9001 and ISO 27001 certifications

Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients. However, while our understanding of AEs should be evolving, and our AE storytelling for patients should be more engaging, reporting of AEs really has not changed. Indeed, AE narratives remain directed at clinicians and regulators, rather than to patients. We believe there is value in being able to tell patients an AE narrative.

read more
Vitaccess rebrand celebrates 4 years of ‘real progress’

Vitaccess rebrand celebrates 4 years of ‘real progress’

Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients. However, while our understanding of AEs should be evolving, and our AE storytelling for patients should be more engaging, reporting of AEs really has not changed. Indeed, AE narratives remain directed at clinicians and regulators, rather than to patients. We believe there is value in being able to tell patients an AE narrative.

read more
Vitaccess wins a Queen’s Award for Enterprise

Vitaccess wins a Queen’s Award for Enterprise

Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients. However, while our understanding of AEs should be evolving, and our AE storytelling for patients should be more engaging, reporting of AEs really has not changed. Indeed, AE narratives remain directed at clinicians and regulators, rather than to patients. We believe there is value in being able to tell patients an AE narrative.

read more
Vitaccess, one of the 50 Game Changers 2021

Vitaccess, one of the 50 Game Changers 2021

ConnectTVT, the platform joining the tech and digital dots in the Thames Valley, has announced the brand new Game Changers 2021 cohort. The programme brings together the Thames Valley’s breakthrough tech and digital startups and scaleups, making global impact in their industries through market-changing technologies, innovation and world-class talent.

read more
Tech Nation announces upscale 6.0 cohort

Tech Nation announces upscale 6.0 cohort

Vitaccess will join 32 other businesses described by Tech Nation as “the UK’s best-performing tech companies” on a six-month program aimed at supercharging growth. The program offers the chance to work with an exciting group of leaders and to tackle the new challenges that founders are facing around remote working, fundraising and culture.

read more
Vitaccess awarded Innovate UK loan

Vitaccess awarded Innovate UK loan

Digital healthcare scale-up Vitaccess announces award of prestigious Innovate UK loan.

Vitaccess, a full-service digital research provider delivering real-time patient-reported data, has been successful in its application for an Innovate UK loan. The funding is provided through loan competitions to UK-based small or medium-sized enterprises (SMEs) by Innovate UK, part of UK Research and Innovation, and the Government’s modern industrial strategy.

read more
Vitaccess donates £10,000 to Melanoma UK

Vitaccess donates £10,000 to Melanoma UK

Award-winning digital health company Vitaccess is delighted to announce that, as part of their syndicated project with patient support charity Melanoma UK, they are donating £10,000 towards an Adamo Horus HS800 mole mapper for the Royal Liverpool and Broadgreen University Hospitals NHS Trust.

read more
See Our FAQ Join the Registry Skip to content